NASDAQ:YI 111 Q2 2025 Earnings Report $3.82 +0.23 (+6.27%) As of 03:20 PM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast 111 EPS ResultsActual EPS-$0.40Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/A111 Revenue ResultsActual Revenue$447.51 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/A111 Announcement DetailsQuarterQ2 2025Date9/17/2025TimeBefore Market OpensConference Call DateTuesday, September 16, 2025Conference Call Time6:00PM ETUpcoming Earnings111's Q3 2026 earnings is estimated for Thursday, November 26, 2026, based on past reporting schedulesConference Call ResourcesPress Release (6-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsEarnings Release(6-K) 111 Earnings Headlines111 (NASDAQ:YI) Announces Earnings ResultsSeptember 20, 2026 | americanbankingnews.comHead-To-Head Analysis: SBC Medical Group (NASDAQ:SBC) & 111 (NASDAQ:YI)September 18, 2026 | americanbankingnews.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.September 25 at 1:00 AM | Altimetry (Ad)111, Inc Q2 Loss Widens From Lower Revenue; Shares UpSeptember 17, 2026 | rttnews.com111, Inc. Posts Q2'26 Results As Asset-Light Shifts Lowers Revenue But Improved Efficiency; Stock UpSeptember 17, 2026 | rttnews.com111 Receives Going-Private Proposal From Co-Founders, Huadeng Tech BioArray VenturesSeptember 17, 2026 | finance.yahoo.comSee More 111 Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like 111? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 111 and other key companies, straight to your email. Email Address About 111111 (NASDAQ:YI), Inc. is a China-based digital healthcare company that operates an online platform connecting consumers, pharmacies, hospitals, pharmaceutical manufacturers and other healthcare participants. The company focuses on improving access to medicines and healthcare products through technology-enabled distribution and retail services. Its business includes online sales and distribution of prescription and over-the-counter medicines, medical devices, nutritional products and other healthcare merchandise. 111 also provides business-to-business services that help pharmacies and medical institutions source products, manage inventory and access digital tools, while its consumer-facing operations offer online medicine and healthcare product purchasing. Founded in 2010 and headquartered in Shanghai, 111 primarily serves the Chinese market. The company was established by Junling Liu, who has served as its chief executive officer and chairman. Its American depositary shares trade on the Nasdaq Global Market under the symbol YI.View 111 ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Costco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic ProblemSuper Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the TestHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Space Stocks to Watch as SpaceX Reshapes the Launch MarketOil May Be Stronger Than It Looks—And Diamondback Is on SaleBlackBerry Shifts Gears With Coretura Deal Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
